GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is one of the most well-documented tripeptides in human biology. First isolated from human plasma by Loren Pickart in 1973, it has since been the subject of extensive research into wound healing, skin biology, anti-inflammatory signalling, and gene expression modulation.
For European researchers, access to high-purity GHK-Cu from a reliable EU warehouse has historically been a challenge. Most suppliers are based in the UK or the United States. Post-Brexit, UK-to-EU shipments carry customs risk. This article covers the research landscape and explains the EU warehouse advantage for European GHK-Cu researchers.
The Science: Why GHK-Cu Is Uniquely Interesting
Gene expression modulation at scale
The most striking research finding regarding GHK-Cu is its breadth of gene regulation activity. A landmark 2012 study by Pickart and Margolina established that GHK-Cu modulates the expression of 4,000+ human genes — approximately 30% of human genome activity related to healing and repair processes.
Published in BioMed Research International (2012), the study documented:
- Upregulation of genes associated with collagen synthesis, tissue repair, and anti-inflammatory responses
- Downregulation of genes associated with cancer progression and inflammation
- Activation of pathways involved in DNA repair and antioxidant defence
This breadth of effect — from a tripeptide with a molecular weight of just 340 g/mol — makes GHK-Cu a uniquely interesting target for longevity and dermatology research.
Collagen synthesis
GHK-Cu stimulates collagen synthesis in fibroblasts at concentrations as low as 1–10 nM. Studies have documented:
- +70% increase in collagen production relative to control in fibroblast culture models
- Upregulation of collagen types I and III (the primary structural collagens of skin and connective tissue)
- Concurrent upregulation of elastin and proteoglycans — suggesting systemic extracellular matrix support
Wound healing and anti-inflammatory effects
- Accelerated wound closure in multiple rodent wound healing models
- Reduction in post-wound scarring
- Anti-inflammatory effects via downregulation of TNF-alpha and IL-6 pathways
- Promotion of angiogenesis — new blood vessel formation in healing tissue
Hair follicle research
GHK-Cu has been studied in the context of androgenic alopecia and hair follicle biology:
- Stimulation of hair follicle size in rodent models
- Activation of follistatin (which inhibits TGF-β1, a driver of hair follicle miniaturisation)
- Documented effects on hair follicle dermal papilla cells in culture studies
GHK-Cu in European Research
European dermatology and longevity research institutions have incorporated GHK-Cu into multiple active research programmes. Key research hubs include Germany, the Netherlands, and France — countries where the compound is classified as a research chemical with no specific regulatory barrier to laboratory acquisition.
German researchers (GHK-Cu kaufen) and French researchers (GHK-Cu achat) have historically had to navigate UK or US imports, with the associated customs risk. The availability of GHK-Cu from EU stock addresses this directly.
Technical Data
Full name: Glycyl-L-histidyl-L-lysine copper(II) complex
CAS number: 49557-75-7
Molecular formula: C14H24CuN6O4
Molecular weight: 403.9 g/mol
Appearance: Dark cobalt blue to deep blue powder (distinctive colour from the copper complex)
Purity (research grade): >99% by HPLC
Solubility: Water-soluble (up to 10 mg/mL in sterile water)
Storage
- Lyophilised (sealed vial): -20°C, stable 24+ months
- Protect from light — the cobalt blue pigment is light-sensitive
- Reconstituted solution: 2–8°C, use within 28 days
Reconstitution
Unlike most research peptides, GHK-Cu dissolves directly in sterile water or Bac Water without requiring acidic conditions. Add 1–2 mL to the vial and gently swirl until fully dissolved.
EU Warehouse: Why It Matters for GHK-Cu
GHK-Cu is chemically stable as a lyophilised powder, but extended exposure to temperature variation, humidity, or light during transit degrades the compound’s activity. Post-Brexit UK-to-EU shipments may spend 2–4 weeks in transit or customs storage — conditions incompatible with reliable research-grade material.
EU warehouse shipments:
- 3–5 day tracked delivery across Germany, France, the Netherlands, Belgium, Austria
- Cold chain maintained in transit
- No customs exposure or delays
- Full tracking from dispatch to delivery
Research Use Only. Not for human consumption. Not a medicinal product.